Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACTB pseudogene 12 (ACTBP12) is a human pseudogene annotated by the HUGO Gene Nomenclature Committee as “ACTB pseudogene 12.” It does not encode a functional protein product but is a genomic DNA sequence highly similar to the functional actin beta (ACTB) or actin gamma (ACTG) genes. Pseudogenes like ACTBP12 have typically lost their protein-coding ability through evolution due to disruptive mutations or the absence of regulatory elements. As a result, ACTBP12 does not serve as a receptor, enzyme, transporter, or any other traditional therapeutic target, nor is it directly associated with any specific biological function or disease. It may have limited utility in genomics as a marker for evolutionary analyses or in studies addressing issues of pseudogene amplification in PCR experiments[5][9][8]. Key scientific points: - ACTBP12 is officially recognized as a pseudogene, not a protein-coding gene or receptor[5][9]. - It does not produce a protein, nor is it implicated in any disease or drug interactions as a direct target. - Pseudogenes, including ACTBP12, can complicate PCR experiments due to sequence similarity with functional genes, but have no established therapeutic relevance[4][8]. - The functional ACTB gene, not this pseudogene, encodes beta-actin, which is well characterized, but ACTBP12 is only a non-functional genomic element[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACTB pseudogene 12 (ACTBP12).